MIXED-WALLED MICROCAPSULES MADE OF CROSS-LINKED PROTEINS AND POLYSACCHARIDES - PREPARATION AND PROPERTIES

被引:24
作者
LEVY, MC
ANDRY, MC
机构
[1] Laboratoire de Pharmacotechnie, URA/CNRS 492, Faculté de Pharmacie, Université de Reims Champagne-Ardenne, Reims Cedex, F51096, 51, rue Cognacq-Jay
关键词
D O I
10.3109/02652049109069560
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Microcapsules were prepared through an interfacial cross-linking process using terephthaloylchloride and applied to mixtures of a protein (human serum albumin or gelatin) and a polysaccharide. Their properties were compared with those of microcapsules prepared from the protein alone. Morphological characteristics of mixed-walled microcapsules were often modified, as seen by light and electron microscopy. Otherwise, they appeared to be more resistant to digestive media: they were gastroresistant, and their degradation time in pancreatin was prolonged upon raising the amount of polysaccharide. Moreover, the lysis time was shown to depend on the nature of the polysaccharide: microcapsules prepared from acidic polysaccharides at pH 9.8 were hydrolyzed faster. Lastly, the resistance increased upon decreasing the polymers/acylchloride ratio, or upon raising the reaction pH. Encapsulation assays were carried out with sodium salicylate, which was incorporated with a high efficiency. Mixed-walled microcapsules allowed a prolonged release of the tracer in vitro. As compared with protein microcapsules, the release profiles of batches prepared with hydroxyethylstarch exhibited only slight modifications of the initial part of the curve, while a significant burst effect was observed with carboxymethylcellulose-containing microcapsules.
引用
收藏
页码:335 / 347
页数:13
相关论文
共 25 条
[1]  
Benita S., Fickat R., Benoit J.P., Bonnemain B., Samaille J.P., Madoule P., Biodegradable cross-linked albumin microcapsules for embolization, Journal of Microencapsulation, 1, pp. 317-327, (1984)
[2]  
Davis S.S., Illum L., McVie J.G., Tomlinson E., Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, (1984)
[3]  
Desoize B., Jardillier J.C., Kanoun K., Guerin D., Levy M.-C., In vitro cytotoxic activity of cross-linked protein microcapsules, Journal of Pharmacy and Pharmacology, 38, pp. 8-13, (1986)
[4]  
Gourdier B., Andry M.-C., Levy M.-C., Microencapsulation VI: Microcapsules à paroi constituée de polyholosides réticulés, 3, pp. 195-204, (1983)
[5]  
Guerin D., Rambourg P., Levy M.-C., Gayot A., Traisnel M., Microencapsulation VIII: Microcapsules de charbon activé à paroi de sérum-albumine humaine réticulée, Innovation et Technologie en Biologie et Médecine, 4, pp. 24-32, (1983)
[6]  
Gupta P.K., Hung C.T., Review. Albumin microspheres II: applications in drug delivery, Journal of Microencapsulation, 6, pp. 463-472, (1989)
[7]  
Lancer L., Biomaterials in controlled drug delivery: new perspectives from biotechnological advances, Pharmaceutical Technology, 13, pp. 18-30, (1989)
[8]  
Ledward D.A., Protein-polysaccharide interactions, Polysaccharides in Food, pp. 205-217, (1979)
[9]  
Lee H.L., Peptide and protein drug delivery: opportunities and challenges, Pharmacy International, 7, pp. 208-212, (1986)
[10]  
Levy M.-C., Andry M.-C., Microencapsulation par réticulation interfaciale de gélatine, Sciences Techniques et Pratiques Pharmaceutiques, 3, pp. 644-651, (1987)